Phase II study of intrabone single unit cord blood transplantation for hematological malignancies

about

Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol.

P2860

Q55331096-270106A8-9F72-45BA-9ACD-F9BA27D767A0

P2860

Phase II study of intrabone single unit cord blood transplantation for hematological malignancies

Item

http://www.wikidata.org/entity/Q38743140

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Phase II study of intrabone si ...... for hematological malignancies

@en

type

Item

label

Phase II study of intrabone si ...... for hematological malignancies

@en

prefLabel

Phase II study of intrabone si ...... for hematological malignancies

@en

P1476

Phase II study of intrabone si ...... for hematological malignancies

@en

P2093

Chisako Iriyama

http://www.w3.org/2001/XMLSchema#string

Hironori Kobayashi

http://www.w3.org/2001/XMLSchema#string

Hitoshi Kiyoi

http://www.w3.org/2001/XMLSchema#string

Masayoshi Masuko

http://www.w3.org/2001/XMLSchema#string

Mitsune Tanimoto

http://www.w3.org/2001/XMLSchema#string

Nobuharu Fujii

http://www.w3.org/2001/XMLSchema#string

Noriko Fukuhara

http://www.w3.org/2001/XMLSchema#string

Seitaro Terakura

http://www.w3.org/2001/XMLSchema#string

Tadashi Matsushita

http://www.w3.org/2001/XMLSchema#string

Tatsunori Goto

http://www.w3.org/2001/XMLSchema#string

P2860

Recent advances in the treatment of adult T-cell leukemia-lymphomas

Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.

One-unit versus two-unit cord-blood transplantation for hematologic cancers.

Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft

Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.

Reduced-intensity conditioning and umbilical cord blood transplantation in adults.

The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases.

P304

1634-1639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13291

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

R Suzuki

Makoto Murata

P577

2017-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28582607

http://www.w3.org/2001/XMLSchema#string

P932

5543458

http://www.w3.org/2001/XMLSchema#string

Phase II study of intrabone single unit cord blood transplantation for hematological malignancies

about

P2860

P2860

Phase II study of intrabone single unit cord blood transplantation for hematological malignancies

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932